Conning Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.6M | Sell |
603,414
-59,334
| -9% | -$3.46M | 1.22% | 20 |
|
|
2025
Q4 | $35.7M | Sell |
662,748
-39,164
| -6% | -$1.88M | 1.2% | 10 |
|
|
2025
Q3 | $31.7M | Sell |
701,912
-14,709
| -2% | -$687K | 1.05% | 51 |
|
|
2025
Q2 | $33.2M | Buy |
716,621
+120,894
| +20% | +$5.93M | 1.14% | 44 |
|
|
2025
Q1 | $36.3M | Sell |
595,727
-54,064
| -8% | -$3.15M | 1.27% | 22 |
|
|
2024
Q4 | $36.8M | Sell |
649,791
-111,332
| -15% | -$6.22M | 1.29% | 15 |
|
|
2024
Q3 | $39.4M | Sell |
761,123
-93,912
| -11% | -$4.41M | 1.3% | 21 |
|
|
2024
Q2 | $35.5M | Buy |
855,035
+122,405
| +17% | +$5.48M | 1.28% | 29 |
|
|
2024
Q1 | $39.7M | Buy |
732,630
+56,543
| +8% | +$2.88M | 1.3% | 21 |
|
|
2023
Q4 | $34.6M | Buy |
676,087
+80,386
| +13% | +$4.22M | 1.2% | 28 |
|
|
2023
Q3 | $34.5M | Buy |
595,701
+40,340
| +7% | +$2.47M | 1.26% | 22 |
|
|
2023
Q2 | $35.4M | Buy |
555,361
+10,929
| +2% | +$733K | 1.19% | 39 |
|
|
2023
Q1 | $37.7M | Buy |
544,432
+62,324
| +13% | +$4.4M | 1.26% | 20 |
|
|
2022
Q4 | $34.6M | Sell |
482,108
-57,435
| -11% | -$4.33M | 1.13% | 42 |
|
|
2022
Q3 | $38.3M | Sell |
539,543
-63,418
| -11% | -$4.6M | 1.36% | 6 |
|
|
2022
Q2 | $46.4M | Sell |
602,961
-65,135
| -10% | -$4.96M | 1.39% | 7 |
|
|
2022
Q1 | $48.8M | Sell |
668,096
-233,159
| -26% | -$15.7M | 1.33% | 11 |
|
|
2021
Q4 | $56.2M | Buy |
901,255
+128,697
| +17% | +$7.55M | 1.5% | 8 |
|
|
2021
Q3 | $45.7M | Sell |
772,558
-22,210
| -3% | -$1.46M | 1.31% | 34 |
|
|
2021
Q2 | $53.1M | Sell |
794,768
-9,945
| -1% | -$648K | 1.54% | 12 |
|
|
2021
Q1 | $50.8M | Buy |
804,713
+32,133
| +4% | +$2M | 1.53% | 24 |
|
|
2020
Q4 | $47.9M | Buy |
772,580
+39,811
| +5% | +$2.45M | 1.52% | 22 |
|
|
2020
Q3 | $44.2M | Buy |
732,769
+7,843
| +1% | +$472K | 1.56% | 18 |
|
|
2020
Q2 | $42.6M | Sell |
724,926
-19,654
| -3% | -$1.18M | 1.58% | 20 |
|
|
2020
Q1 | $41.5M | Buy |
744,580
+702,269
| +1,660% | +$42.9M | 1.77% | 12 |
|
|
2019
Q4 | $2.72M | Buy |
42,311
+15,717
| +59% | +$900K | 0.09% | 123 |
|
|
2019
Q3 | $1.35M | Sell |
26,594
-79
| -0.3% | -$3.71K | 0.05% | 189 |
|
|
2019
Q2 | $1.21M | Sell |
26,673
-8,948
| -25% | -$417K | 0.04% | 199 |
|
|
2019
Q1 | $1.7M | Sell |
35,621
-80
| -0.2% | -$3.98K | 0.05% | 192 |
|
|
2018
Q4 | $1.86M | Sell |
35,701
-3,190
| -8% | -$171K | 0.06% | 171 |
|
|
2018
Q3 | $2.41M | Sell |
38,891
-68,878
| -64% | -$4.09M | 0.07% | 161 |
|
|
2018
Q2 | $5.96M | Sell |
107,769
-427,196
| -80% | -$23.1M | 0.18% | 95 |
|
|
2018
Q1 | $33.8M | Buy |
534,965
+61,051
| +13% | +$3.93M | 1.09% | 43 |
|
|
2017
Q4 | $29M | Sell |
473,914
-7,574
| -2% | -$474K | 0.96% | 48 |
|
|
2017
Q3 | $30.7M | Sell |
481,488
-57,655
| -11% | -$3.37M | 1.04% | 39 |
|
|
2017
Q2 | $30M | Buy |
539,143
+56,180
| +12% | +$3.06M | 1.09% | 37 |
|
|
2017
Q1 | $26.3M | Buy |
482,963
+33,556
| +7% | +$1.84M | 0.97% | 45 |
|
|
2016
Q4 | $26.3M | Buy |
449,407
+17,211
| +4% | +$941K | 1.05% | 37 |
|
|
2016
Q3 | $23.3M | Buy |
432,196
+385,910
| +834% | +$24.8M | 0.93% | 47 |
|
|
2016
Q2 | $3.4M | Sell |
46,286
-7,120
| -13% | -$503K | 0.14% | 125 |
|
|
2016
Q1 | $3.41M | Sell |
53,406
-5,020
| -9% | -$317K | 0.14% | 124 |
|
|
2015
Q4 | $4.02M | Buy |
58,426
+4,420
| +8% | +$292K | 0.17% | 112 |
|
|
2015
Q3 | $3.2M | Sell |
54,006
-4,370
| -7% | -$277K | 0.14% | 125 |
|
|
2015
Q2 | $3.88M | Sell |
58,376
-350
| -0.6% | -$23.1K | 0.16% | 112 |
|
|
2015
Q1 | $3.79M | Sell |
58,726
-160
| -0.3% | -$10K | 0.16% | 98 |
|
|
2014
Q4 | $3.48M | Sell |
58,886
-9,290
| -14% | -$524K | 0.17% | 101 |
|
|
2014
Q3 | $3.49M | Sell |
68,176
-840
| -1% | -$42K | 0.18% | 97 |
|
|
2014
Q2 | $3.35M | Sell |
69,016
-2,520
| -4% | -$124K | 0.18% | 99 |
|
|
2014
Q1 | $3.72M | Sell |
71,536
-3,230
| -4% | -$172K | 0.22% | 88 |
|
|
2013
Q4 | $3.97M | Sell |
74,766
-243,621
| -77% | -$12.4M | 0.25% | 85 |
|
|
2013
Q3 | $14.7M | Buy |
318,387
+35,113
| +12% | +$1.54M | 1.14% | 19 |
|
|
2013
Q2 | $12.7M | Buy |
+283,274
| New | +$12.3M | 1.05% | 28 |
|
Other funds holding BMY
VCM
VPM
Conning Inc's BMY Position: Q1 2026 in Review
Conning Inc reduced its Bristol-Myers Squibb (BMY) stake by 9% in Q1 2026, selling an estimated $3.46M and leaving 603,414 shares worth $36.6M. The position accounts for 1.22% of the portfolio, ranked #20.
Conning Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.2M in Q4 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Conning Inc held 603,414 shares of Bristol-Myers Squibb worth $36.6M as of Q1 2026.
- Conning Inc sold 59,334 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.46M.
- Bristol-Myers Squibb made up 1.22% of Conning Inc's portfolio in Q1 2026, its #20 holding.
- Conning Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Conning Inc's Bristol-Myers Squibb position peaked at $56.2M in Q4 2021.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.